Researchers have shown for the first time how children can inherit a severe – potentially fatal – mitochondrial disease from a healthy mother. The study, led by researchers from the MRC Mitochondrial Biology Unit at the University of Cambridge, reveals that healthy people harbour mutations in their mitochondrial DNA and explains how cases of severe mitochondrial disease can appear unexpectedly in previously unaffected families.
The Government have announced £5.4 million in funding to launch the Centre for Digital Built Britain at the University of Cambridge, which will help people make better use of cities by championing the digital revolution in the built environment. The Centre is part of a landmark government-led investment in growing the UK’s construction sector.
A group of researchers from the UK and the US have used machine learning techniques to successfully predict earthquakes. Although their work was performed in a laboratory setting, the experiment closely mimics real-life conditions, and the results could be used to predict the timing of a real earthquake.
Boy or girl? This is one of the first questions all new parents are asked. In a small percentage of cases, the answer isn’t straightforward: the child is intersex. In a highly gendered society, how does the law apply to people whose physiology doesn’t fit the binary categories of male and female?
Could replicants ever be a reality? In this article from The Conversation, Fumiya Iida (Department of Engineering) discusses what it would take to make a truly life-like robot.
Despite the value that humans get from nature, it is not included in measurements of poverty and well-being. Cambridge's Judith Schleicher and Bhaskar Vira say it's about time this changed.
A political leader who seeks to make his nation “great again” and a time when ‘post-truth’ rhetoric appears to support political ambitions. Not Trump’s America, but Rome 2,000 years ago.
When a drug fails late on in clinical trials it’s a major setback for launching new medicines. It can cost millions, even billions, of research and development funds. Now, an ‘adaptive’ approach to clinical trials and a genetic tool for predicting success are increasing the odds of picking a winner.
Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer’s disease, and stop their production.